
1. antimicrob agents chemother. 2013 jan;57(1):417-24. doi: 10.1128/aac.00793-12.
epub 2012 nov 5.

4(1h)-quinolones liver stage activity plasmodium berghei.

lacrue an(1), s√°enz fe, cross rm, udenze ko, monastyrskyi a, stein s, mutka ts,
manetsch r, kyle de.

author information: 
(1)department global health, university south florida, tampa, florida, usa.

with exception primaquine, tafenoquine, atovaquone, few
antimalarials target liver stage parasites. study, transgenic
plasmodium berghei parasite (1052cl1; pbgfp-luc(con)) expresses luciferase
was used assess anti-liver stage parasite activity ici 56,780, a
7-(2-phenoxyethoxy)-4(1h)-quinolone (peq), well two
3-phenyl-4(1h)-quinolones (p4q), p4q-146 p4q-158, using bioluminescent
imaging (bli). results showed compounds active liver
stage parasites; however, ici 56,780 p4q-158 active, low
nanomolar activity vitro causal prophylactic activity vivo. potent
activity makes compounds ideal candidates advancement novel
antimalarials.

doi: 10.1128/aac.00793-12 
pmcid: pmc3535941
pmid: 23129047  [indexed medline]

